NDC 35573-413

Methocarbamol

Methocarbamol

Methocarbamol is a Oral Tablet, Coated in the Human Prescription Drug category. It is labeled and distributed by Burel Pharmaceuticals, Inc.. The primary component is Methocarbamol.

Product ID35573-413_14e20dbc-f4b4-11e9-802a-5aa538984bd8
NDC35573-413
Product TypeHuman Prescription Drug
Proprietary NameMethocarbamol
Generic NameMethocarbamol
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2019-09-30
Marketing CategoryANDA / ANDA
Application NumberANDA209312
Labeler NameBurel Pharmaceuticals, Inc.
Substance NameMETHOCARBAMOL
Active Ingredient Strength500 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 35573-413-02

100 TABLET, COATED in 1 BOTTLE (35573-413-02)
Marketing Start Date2019-09-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 35573-413-02 [35573041302]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-09-30

NDC 35573-413-04 [35573041304]

Methocarbamol TABLET, COATED
Marketing CategoryANDA
Application NumberANDA209312
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-09-30

Drug Details

Active Ingredients

IngredientStrength
METHOCARBAMOL500 mg/1

Pharmacological Class

  • Centrally-mediated Muscle Relaxation [PE]
  • Muscle Relaxant [EPC]
  • Centrally-mediated Muscle Relaxation [PE]
  • Muscle Relaxant [EPC]